5 completed, 2 terminated, 1 active not recruiting, 1 unknown. 9 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 5, Terminated 2, Active not recruiting 1, Unknown 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Nicoderm: new trials by email Literature Review of Nicoderm trials Research Report on Nicoderm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders Nicoderm, Nicorette 4Mg Chewing Gum, Nicorette Lozenge Product - Smoking Cessation, Harm Reduction | Phase 3 | Completed | Rose Research Center, LLC | 150 | 2024-08-29 | 2026-02-06 |
| Evaluate Harm Reduction Products as a Second Line Intervention for Adult Smokers Who Do Not Quit With NRT Nicoderm, Nicorette 4Mg Chewing Gum, Nicorette Lozenge Product - Smoking Cessation, Harm Reduction | Phase 3 | Terminated | Rose Research Center, LLC | 4 | 2023-12-27 | 2025-03-30 |
| Optimizing Tobacco Use Treatment for PLWHA Varenicline, Nicotine patch, Standard treatment - HIV/AIDS, Nicotine Dependence | Phase 3 | Active not recruiting | Abramson Cancer Center at Penn Medicine | 340 | 2020-02-17 | 2026-09-04 |
| Individualizing Pharmacotherapy for African American Smokers Nicotine patch, Varenicline Tartrate, Bupropion - Smoking Cessation | Phase 3 | Completed | University of Kansas Medical Center | 392 | 2019-05-01 | 2023-04-03 |
| Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement Nicotine patch, Nicotine mouthspray - Tobacco Use Disorder, Nicotine Dependence | Phase 2 / Phase 3 | Terminated | Centre for Addiction and Mental Health | 18 | 2015-07-01 | 2018-07-19 |
| The Canadian HIV Quit Smoking Trial: Tackling the Co-morbidities of Depression and Cardiovascular Disease in HIV+ Smokers Nicotine Replacement Therapy (NRT), Varenicline, HIV Tailored Quit Smoking Counseling - HIV, Smoking Cessation | Phase 3 | Unknown | Ottawa Hospital Research Institute | 256 | 2014-01-01 | 2015-12-14 |
| Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation Varenicline, Bupropion, Nicotine patches - Nicotine Dependence | Phase 3 | Completed | Duke University | 282 | 2011-07-01 | 2017-11-14 |
| Concurrent Bupropion / Varenicline for Smoking Cessation Varenicline, Bupropion, Nicotine patches - Nicotine Dependence | Phase 3 | Completed | Duke University | 702 | 2011-03-01 | 2014-08-06 |
| Topiramate Alone and in Combination With the Nicotine Patch for Smoking Cessation: A Pilot Study Placebo (sugar pill), Topiramate, Nicotine patch - Tobacco Dependence | Phase 3 | Completed | UConn Health | 57 | 2006-04-01 | 2017-08-16 |
Smoking Cessation (8) · Tobacco Use Disorder (5) · Cigarette Smoking (3) · Harm Reduction (2) · Acquired Immunodeficiency Syndrome (1) · Smoking (1)
Duke University (2) · Rose Research Center, LLC (2) · Abramson Cancer Center at Penn Medicine (1) · Centre for Addiction and Mental Health (1) · Ottawa Hospital Research Institute (1) · UConn Health (1) · University of Kansas Medical Center (1)
United States (7) · Canada (2)
Cheryl A Oncken, MD (1) · F. Joseph McClernon, Ph.D. (1) · Jed E Rose, Ph.D. (1) · Laurie Zawertailo, PhD (1) · Louise Balfour, PhD (1) · Nicole Nollen, PhD (1) · Peter Selby, MBBS (1) · Robert Schnoll, PhD (1)
PMID 34611902, PMID 37142273, PMID 24057996, PMID 24934962, PMID 36387983, PMID 37338906, PMID 39976595
P50DA027840 (2), K24AA013736 (1), M01RR006192 (1), R01CA243914 (1), R01DA046576 (1)